Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1Phase 1/2 1Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 10Carcinoma, Non-Small-Cell Lung 6Prostatic Neoplasms 4Lymphoma, Large B-Cell, Diffuse 4Leukemia, Myeloid, Acute 4Triple Negative Breast Neoplasms 3Stomach Neoplasms 3Recurrence 3Ovarian Neoplasms 3Neoplasm Metastasis 3Multiple Myeloma 3Lung Neoplasms 3Thrombosis 2Squamous Cell Carcinoma of Head and Neck 2Small Cell Lung Carcinoma 2Neoplasms 2Nasopharyngeal Carcinoma 2Esophageal Squamous Cell Carcinoma 2Disease 2Carcinoma, Transitional Cell 2Carcinoma, Hepatocellular 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Cancer, Papillary 1Thrombophilia 1Thrombocytopenia 1Thoracic Neoplasms 1Skin Neoplasms 1Pituitary Neoplasms 1Pediatric Solid Tumor, Unspecified, Protocol Specific 1

Interventions

Gemcitabine 18Cisplatin 13Oxaliplatin 8Capecitabine 7Leucovorin 6Fluorouracil 5pembrolizumab 4Photochemotherapy 3Irinotecan 3ivosidenib 2Cholangiopancreatography, Endoscopic Retrograde 2zanidatamab 1toripalimab 1pemigatinib 1lenvatinib 1infigratinib 1durvalumab 1cemiplimab 1becatecarin 1atezolizumab 1Tissue Adhesives 1Tegafur 1Taxes 1S 1 (combination) 1Radiotherapy, Image-Guided 1Radiation 1Platinum 1Pancreaticojejunostomy 1Nivolumab 1Neoadjuvant Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Cholangiocarcinoma × Injections × Clear all
NCT05342194 2025-04-23

Toripalimab Plus Lenvatinib and Gemcitabine-based Chemotherapy in 1L Treatment of Advanced ICC: a Phase III Study

Shanghai Junshi Bioscience Co., Ltd.

Phase 3 Recruiting
480 enrolled
Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡